Repligen | RGEN - Заемный капитал

Биржевая цена
123.46
Изменение за день
-2.97 -2.35%
Ежемесячно
3.07%
Ежегодный
0.18%
Q2 прогноз
114.76




Заемный капитал Изменить Дата
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Bio Techne USD 200M 60M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.01B 9M 2026-03
General Electric Aerospace USD 18.17B 634M 2026-03
Henry Schein USD 2.33B 17M 2026-03
Illumina USD 1.49B 0 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Mettler Toledo International USD 2.16B 73.35M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Pfizer USD 60.57B 1.08B 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 2.63B 836K 2026-03
Standard Biotools USD 299K 0 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Waters USD 5.22B 3.81B 2026-03
West Pharmaceutical Services USD 202.8M 0 2026-03